IRADIMED CORPORATION Announces Second Quarter 2021 Financial Results
iRadimed Corporation (IRMD)
Last iradimed corporation earnings: 4/30 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
iradimed.com/en-us/investors/investor-contact
Company Research
Source: GlobeNewswire
Reports second quarter 2021 revenue of $9.8 million, GAAP diluted EPS of $0.12 and non-GAAP diluted EPS of $0.14Issues Q3 and full year 2021 financial guidance WINTER SPRINGS, Fla., July 30, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system, and non-magnetic patient vital signs monitoring systems that are designed for use during MRI procedures, today announced financial results for the three and six months ended June 30, 2021. “This quarter marks another record high in total bookings for our products, giving us confidence and optimism for the second half of 2021. Our second quarter financial results are a continuation of the growth trends we have seen over the last four quarters since the rise of COVID-19. I am very proud of our team and their resilience in overcoming the chall
Show less
Read more
Impact Snapshot
Event Time:
IRMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IRMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IRMD alerts
High impacting iRadimed Corporation news events
Weekly update
A roundup of the hottest topics
IRMD
News
- Iradimed Corporation (NASDAQ: IRMD) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $65.00 price target on the stock.MarketBeat
- Iradimed Corporation (NASDAQ: IRMD) had its "buy" rating re-affirmed by analysts at Singular Research.MarketBeat
- IRADIMED CORPORATION's (NASDAQ:IRMD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? [Yahoo! Finance]Yahoo! Finance
- IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference [Yahoo! Finance]Yahoo! Finance
- IRADIMED CORPORATION To Participate at the 36th Annual Roth ConferenceGlobeNewswire
IRMD
Earnings
- 2/8/24 - Beat
IRMD
Analyst Actions
- 4/5/24 - Singular Research
IRMD
Sec Filings
- 4/3/24 - Form S-3
- 3/1/24 - Form 10-K
- 2/13/24 - Form SC
- IRMD's page on the SEC website